Adm Tronics Unlimited Inc (ADMT) |
|
Price: $0.1070
$0.01
4.902%
|
Day's High:
| $0.1085
| Week Perf:
| -10.83 %
|
Day's Low: |
$ 0.10 |
30 Day Perf: |
-20.15 % |
Volume (M): |
3 |
52 Wk High: |
$ 0.15 |
Volume (M$): |
$ 0 |
52 Wk Avg: |
$0.10 |
Open: |
$0.11 |
52 Wk Low: |
$0.05 |
|
|
Market Capitalization (Millions $) |
7 |
Shares
Outstanding (Millions) |
68 |
Employees |
21 |
Revenues (TTM) (Millions $) |
4 |
Net Income (TTM) (Millions $) |
0 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Adm Tronics Unlimited Inc
The Company is a technology-based developer and manufacturer of diversified
lines of products and derives revenue from the production and sale of electronics
for medical devices and other applications; environmentally safe chemical products
for industrial, medical and cosmetic uses; and, research, development, regulatory
and engineering services.
The Company is a corporation that was organized under the laws of the State
of Delaware on November 24, 1969. Our operations are conducted through ADM Tronics
Unlimited, Inc. ("ADM") and its subsidiary Sonotron Medical Systems,
Inc. ("SMI").
ELECTRONICS FOR MEDICAL DEVICES AND OTHER APPLICATIONS
We develop and manufacture electronic technologies for non-invasive, electrotherapeutic
and diagnostic medical devices as well as for veterinary and other applications.
The products are manufactured at our Northvale facility which is an FDA-Registered
Medical Device Manufacturing facility. We develop and manufacture our own proprietary
products as well as on a contract basis for other companies.
CONTRACT MANUFACTURING
The Company derives revenues from contract manufacturing of electronic medical
and other devices from non-affiliated customers.
SONOTRON TECHNOLOGY
SMI, a majority-owned subsidiary of ADM, has developed a technology, known as
the Sonotron Technology, to treat subjects suffering from the pain of inflammatory
joint conditions. Although some of the devices utilizing this technology are
commercially available for the treatment of animals, none of such devices have
received clearance from the U.S. Food and Drug Administration (the "FDA")
for human application in the United States. Pursuant to a manufacturing agreement,
the Company is the exclusive manufacturer of the Sonotron devices. The Sonotron
Technology is the subject of a United States patent (the "Sonotron Patent"),
which expired in April 2016.
We develop, manufacture and sell chemical products to industrial users. Such
products consist primarily of the following:
Water-based primers and adhesives;
Water-based coatings and resins;
Water-based chemical additives; and
Anti-static conductive paints, coating and other products.
Water-based primers and adhesives are chemical compounds used to bind different
plastic films, metal foils and papers. Examples are the binding of polyethylene
to polyester, nylon, vinyl, aluminum, polypropylene, paper and cellophane. Our
water-based primers and adhesives are similar in function to solvent-based primers
that are widely used to bind plastic films, papers and foils. Solvent-based
systems have come under criticism since they have been found to be highly pollutant,
dangerous to health and generally caustic in nature. Based upon our experience
since 1969, including information furnished to us by certain of our customers,
we believe that water-based systems have no known polluting effects and pose
no known health hazards. There can, of course, be no assurance that any governmental
restrictions will not be imposed on our water-based products or that such products
will be accepted as replacements for solvent based products.
Water-based coatings and resins for the printing industry are used to impart
properties to the printed substrate. Our coatings and resins can be used to
coat printed material for glossy or aesthetic appeal to make such material virtually
impervious to certain types of grease and to impart other characteristics required
or desired for various products and specifications.
Certain of our water-based chemical additives are used to impart properties
to inks and other chemical products used in the food packaging and printing
industries. These additives are used for their ability to improve the performance
of such products.
Through Anti-Static Industries, the assets of which were acquired in July 2009,
we now develop and manufacture a full-line of anti-static products for commercial
and industrial use through a division of our company that we refer to as “Antistatic
Industries”. Antistatic Industries develops and distributes proprietary
conductive paints, coatings and other products and accessories which can be
used by electronics, computer, pharmaceutical and chemical companies to prevent,
reduce or eliminate static electricity. Many industries are concerned with static
electricity as it can be hazardous to personnel and damage corporate facilities,
computers, electronic equipment and valuable parts. Antistatic Industries has
a wide range of products including paints, hoses, garments, floor mats, rugs,
strapping, tapes, hook-and-loop, adhesive products and many other specialized
items, all with conductive properties. Antistatic Industries has also pioneered
low volatile organic compound conductive and antistatic paint and coating formulations
that can be used as replacements for paints and coatings made from hazardous
solvents. Antistatic Industries seeks to continually develop new products through
research and development for new and current customers to aid in their quest
for maximum protection with less waste and rejects in their manufacturing processes
by reducing or eliminating static electricity.
None of our chemical products are protected by patents, although the names of
some of such products have been protected by trademarks. We do not believe that
any such trademarks are material to our business.
MEDICAL AND COSMETIC PRODUCTS
The Company has developed several medical and cosmetic topical products. The
Company’s proprietary water-based, adhesive and related topical formulations
are used for maxillofacial prosthetic medical applications and for professional
makeup applications primarily for special makeup effects for film, TV and theatrical
productions.
RESEARCH, DEVELOPMENT, REGULATORY AND ENGINEERING SERVICES
The Company provides research, development, regulatory and engineering services
to unaffiliated customers for the design, development and manufacturing of medical
devices, electronics and other technologies and products (the “Engineering
Services”). The Engineering Services are provided by the Company to customers
both on a fee-for-services basis and on a project basis.
Company Address: 224-S Pegasus Ave. Northvale 7647 NJ
Company Phone Number: 767-6040 Stock Exchange / Ticker: ADMT
ADMT is expected to report next financial results on November 20, 2023. |
|
|
|
Customers Net Income grew by |
ADMT's Customers Net Profit Margin grew to |
|
15.49 %
|
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Heart Test Laboratories Inc
Heart Test Laboratories Inc, a medical device manufacturing company, recently released its financial results for the first quarter of the 2024 earnings season. The figures demonstrate a significant decrease in loss per share compared to the previous year, as well as an improvement in earnings per share. Although the revenue remained unchanged, the company reported a lower net shortfall compared to the same reporting season the previous year. This article aims to provide an overview of Heart Test Laboratories Inc's Q1 2024 financial results and analyze them within the context of recent stock performance. Financial Results: Heart Test Laboratories Inc reported a loss per share of $-0.13 in the first quarter of 2024, a considerable improvement from the loss per share of $-0.28 in the same reporting season the previous year. Additionally, the company's earnings per share increased from $-0.16 in the previous reporting season. Despite these positive developments, the revenue for Q1 2024 remained unchanged at $0.00 million, both compared to the same reporting season a year before and sequentially.
|
Sensasure Technologies Inc
Date: August 1, 2023 As the financial interval closing July 31, 2023 draws to a close, Sensasure Technologies Inc, a leading technology company, has achieved a significant milestone by reaching break-even at $0.00 per share. This marks an improvement from the same reporting period a year ago when the company also reported a break-even, and from the preceding reporting period. However, while this is an encouraging development for Sensasure Technologies Inc, it is crucial to examine the context of the financial results to gain deeper insights.
|
Innovage Holding Corp
Innovage Holding Corp, a Medical Equipment and Supplies company, recently released its financial results for the fourth quarter of 2023. Despite reporting a loss of $0.08 per share, compared to $0.09 in the previous year, the company's revenue grew moderately by 2.322% to $176.87 million. However, this revenue surge was lower than the average growth rate of 4.80% for the Medical Equipment and Supplies sector during the same period. Analysts believe that this slower growth may be due to a decline in demand, as evidenced by the decrease in accounts receivable to $24.3 million.
|
Lakeland Industries Inc
Lakeland Industries Inc, a leading Medical Equipment and Supplies company, has delivered impressive financial results for the most recent fiscal period, outpacing its industry contemporaries. The company reported a positive bottom-line of $0.32 per share, a significant improvement compared to the negative $0.11 per share from the previous year. This translates to a staggering 77.78% increase in earnings per share from $0.18 in the previous reporting period. The revenue growth for Lakeland Industries Inc has been equally impressive, with a substantial increase of 17.34% to $33.07 million from $28.18 million in the corresponding period a year ago. Moreover, their sequential revenue growth improved by 15.23% from $28.70 million. In sharp contrast, the rest of the Medical Equipment and Supplies industry only witnessed a 4.18% revenue improvement during the same period. This clearly highlights Lakeland Industries Inc's exceptional performance in the market.
|
The Cooper Companies Inc
Medical Equipment and Supplies Company, The Cooper Companies Inc, experienced a decline in earnings per share (EPS) despite a rise in revenue for the financial period ending on July 31, 2023. Although revenue increased by a significant 10.268% to $930.00 million compared to the previous year, income fell by -13.64% to $1.71 per share. Despite the decline in EPS, the company's revenue surge in the third quarter of 2023 surpassed its industry peers, which only experienced a 4.05% overall business increase during the same period. Comparing to the previous reporting period, EPS showed impressive growth of 113.75% from $0.80 per share, while revenue improved by 5.995% from $877.40 million. However, net earnings declined by -13.31% to $85.300 million at the end of July, compared to $98.400 million in the same period a year earlier. The Cooper Companies Inc focused on improving sales during the financial period, leading to a net margin decrease to 9.17%. Additionally, there has been a noticeable buildup in inventories, with inventories and supplies reaching $723.6 million, higher than the previous and corresponding quarter of the previous year. On a positive note, operating earnings rose by 7.82% to $151.6 million. The increase in accounts receivable also indicates rising demand, with a value of $629.9 million, higher than the preceding quarter. Looking into the future performance, The Cooper Companies Inc shares recorded a decline of -0.19% over the past five trading days, resulting in a year-to-date performance of 11.63%. The shares are currently 7.1% short of the 52-week highInvestors will be eagerly waiting to see the next financial numbers from The Cooper Companies Inc, which are expected to be reported on December 08, 2023. With a focus on improving sales and a noticeable buildup in inventories and accounts receivable, the company may be positioning itself for future growth despite the recent decline in EPS.
|
Per Share |
Current |
Earnings (TTM) |
-0 $ |
Revenues (TTM) |
0.05 $
|
Cash Flow (TTM) |
- |
Cash |
0.01 $
|
Book Value |
0.02 $
|
Dividend (TTM) |
0 $ |
|
Per Share |
|
Earnings (TTM) |
-0 $
|
Revenues (TTM) |
0.05 $ |
Cash Flow (TTM) |
- |
Cash |
0.01 $
|
Book Value |
0.02 $ |
Dividend (TTM) |
0 $ |
|
|
|
|